Breast Cancer Registry
Trial Overview
Official Title
Integrated Cancer Repository for Cancer Research (iCaRe2) – Breast Cancer Collaborative Repository
Study Purpose
This registry/tissue bank focuses on the collection of detailed information and biological samples to help create a resource that will be helpful to cancer researchers to study risk factors for a number of different types of cancer and other diseases, which relate to cancer.
Diagnosis
Breast CancerEligibility
Must have breast cancer or have an increased risk of developing breast cancer.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
Intervention
- Quality of Life Questionnaires
- Will be asked to submit a blood sample to be stored.
- If there is any available tissue from a patient’s cancer that is currently being stored, a sample of that will be submitted to be stored for future research.
For more information, click the link below:
https://clinicaltrials.gov/study/NCT02012699?term=Breast%20Cancer%20Registry&page=19&rank=185
Key Participation Requirements
Trial Location(s)
Gender
Male or Female
Age
19 years and older
Enrollment Status
Recruiting
Phase
Not Applicable
Methodist Health System Trial Code
Registry